IL-1β blockade has been shown to reverse immunosuppression and has been shown to exhibit synergy with PD-1 inhibitors to promote the elimination of several tumor types, including breast [32], pancreatic [18], and renal [33] tumors. This evidence concerns the gene PDCD1 and neoplasm.